Invariant	B-protein
chain	I-protein
induces	O
B	O
cell	O
maturation	O
by	O
activating	O
a	O
TAF	B-protein
(	I-protein
II	I-protein
)	I-protein
105-NF-kappaB	I-protein
-dependent	O
transcription	O
program	O
.	O

Early	O
stages	O
of	O
B	O
cell	O
development	O
occur	O
in	O
the	O
bone	O
marrow	O
,	O
resulting	O
in	O
formation	O
of	O
immature	B-cell_type
B	I-cell_type
cells	I-cell_type
.	O

From	O
there	O
these	O
immature	B-cell_type
cells	I-cell_type
migrate	O
to	O
the	O
spleen	O
where	O
they	O
differentiate	O
to	O
mature	B-cell_type
cells	I-cell_type
.	O

This	O
final	O
maturation	O
step	O
is	O
crucial	O
for	O
the	O
B	B-cell_type
cells	I-cell_type
to	O
become	O
responsive	O
to	O
antigens	B-protein
and	O
to	O
participate	O
in	O
the	O
immune	O
response	O
.	O

Recently	O
,	O
invariant	B-protein
chain	I-protein
(	O
Ii	B-protein
)	O
,	O
a	O
major	B-protein
histocompatibility	I-protein
complex	I-protein
class	I-protein
II	I-protein
chaperone	I-protein
,	O
as	O
well	O
as	O
the	O
transcription	B-protein
factors	I-protein
c-Rel	B-protein
and	O
p65/RelA	B-protein
,	O
were	O
found	O
to	O
play	O
a	O
role	O
in	O
the	O
final	O
antigen-independent	O
differentiation	O
stage	O
of	O
B	B-cell_type
cells	I-cell_type
in	O
the	O
spleen	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
a	O
possible	O
link	O
between	O
Ii	B-protein
-dependent	O
B	O
cell	O
maturation	O
and	O
the	O
NF-kappaB	O
pathway	O
.	O

Our	O
studies	O
indicate	O
that	O
Ii	B-protein
-induced	O
B	O
cell	O
maturation	O
involves	O
activation	O
of	O
transcription	O
mediated	O
by	O
the	O
NF-kappaB	B-protein
p65/RelA	I-protein
homodimer	I-protein
and	O
requires	O
the	O
B	B-protein
cell-enriched	I-protein
coactivator	I-protein
TBP-associated	B-protein
factor	I-protein
(	I-protein
II	I-protein
)	I-protein
105	I-protein
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

276	NULL
,	NULL
No	NULL
.	NULL

29	NULL
,	NULL
Issue	NULL
of	NULL
July	NULL
20	NULL
,	NULL
pp	NULL
.	NULL

27203-27206	NULL
,	NULL
2001	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Invariant	NULL
Chain	NULL
Induces	NULL
B	NULL
Cell	NULL
Maturation	NULL
by	NULL
Activating	NULL
a	NULL
TAF	NULL
,	NULL
,105-NF-B-dependent	NULL
Transcription	NULL
Program*	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
May	NULL
22	NULL
,	NULL
2001	NULL
Published	NULL
,	NULL
JBC	NULL
Papers	NULL
in	NULL
Press	NULL
,	NULL
May	NULL
22	NULL
,	NULL
2001	NULL
,	NULL
DOI	NULL
10.1074/jbe.M104684200	NULL
Didi	NULL
Matza	NULL
#	NULL
§	NULL
,	NULL
Orit	NULL
Wolstein§1	NULL
,	NULL
Rivka	NULL
Dikstein1|**	NULL
,	NULL
and	NULL
Idit	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
{	NULL
Immunology	NULL
and	NULL
Biological	NULL
Chemistry	NULL
,	NULL
The	NULL
Weizmann	NULL
Institute	NULL
of	NULL
Science	NULL
,	NULL
Rehovot	NULL
76100	NULL
,	NULL
Israel	NULL
Early	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
occur	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
,	NULL
resulting	NULL
in	NULL
formation	NULL
of	NULL
immature	NULL
B	NULL
cells	NULL
.	NULL

From	NULL
there	NULL
these	NULL
immature	NULL
cells	NULL
migrate	NULL
to	NULL
the	NULL
spleen	NULL
where	NULL
they	NULL
differentiate	NULL
to	NULL
mature	NULL
cells	NULL
.	NULL

This	NULL
final	NULL
maturation	NULL
step	NULL
is	NULL
crucial	NULL
for	NULL
the	NULL
B	NULL
cells	NULL
to	NULL
become	NULL
responsive	NULL
to	NULL
antigens	NULL
and	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

Recently	NULL
,	NULL
invariant	NULL
chain	NULL
(	NULL
i	NULL
)	NULL
,	NULL
a	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
chaperone	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
transcription	NULL
factors	NULL
c-Rel	NULL
and	NULL
p65/RelIA	NULL
,	NULL
were	NULL
found	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
final	NULL
antigen-independent	NULL
differentiation	NULL
stage	NULL
of	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
spleen	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
a	NULL
possible	NULL
link	NULL
between	NULL
Ii-dependent	NULL
B	NULL
cell	NULL
maturation	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
.	NULL

Our	NULL
studies	NULL
indicate	NULL
that	NULL
Ii-induced	NULL
B	NULL
cell	NULL
maturation	NULL
involves	NULL
activation	NULL
of	NULL
transcription	NULL
mediated	NULL
by	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65/ReIA	NULL
homodimer	NULL
and	NULL
requires	NULL
the	NULL
B	NULL
cell-enriched	NULL
coactivator	NULL
TBP	NULL
-associated	NULL
factor	NULL
105	NULL
.	NULL

In	NULL
the	NULL
bone	NULL
marrow	NULL
,	NULL
B	NULL
cell	NULL
development	NULL
can	NULL
be	NULL
divided	NULL
into	NULL
different	NULL
stages	NULL
,	NULL
based	NULL
on	NULL
the	NULL
rearrangement	NULL
status	NULL
of	NULL
the	NULL
IgH	NULL
and	NULL
IgL	NULL
chain	NULL
loci	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
intracellular	NULL
and	NULL
surface-bound	NULL
markers	NULL
.	NULL

The	NULL
first	NULL
cells	NULL
expressing	NULL
IgM	NULL
during	NULL
this	NULL
developmental	NULL
process	NULL
are	NULL
the	NULL
immature	NULL
B	NULL
cells	NULL
.	NULL

At	NULL
this	NULL
stage	NULL
in	NULL
their	NULL
development	NULL
the	NULL
B	NULL
cells	NULL
translocate	NULL
from	NULL
the	NULL
bone	NULL
marrow	NULL
to	NULL
the	NULL
spleen	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

In	NULL
the	NULL
spleen	NULL
,	NULL
B	NULL
cells	NULL
are	NULL
still	NULL
immature	NULL
and	NULL
are	NULL
distinguishable	NULL
from	NULL
their	NULL
mature	NULL
counterparts	NULL
(	NULL
3	NULL
,	NULL
5-7	NULL
)	NULL
.	NULL

The	NULL
subsequent	NULL
differentiation	NULL
event	NULL
leads	NULL
to	NULL
mature	NULL
B	NULL
cells	NULL
and	NULL
is	NULL
characterized	NULL
by	NULL
a	NULL
series	NULL
of	NULL
changes	NULL
in	NULL
surface	NULL
marker	NULL
expression	NULL
and	NULL
in	NULL
the	NULL
activities	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

Only	NULL
5	NULL
to	NULL
10	NULL
%	NULL
of	NULL
the	NULL
newly	NULL
generated	NULL
immature	NULL
B	NULL
cells	NULL
are	NULL
selected	NULL
into	NULL
the	NULL
pool	NULL
of	NULL
long-lived	NULL
antigen-responsive	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
mechanisms	NULL
controlling	NULL
the	NULL
selection	NULL
of	NULL
immature	NULL
B	NULL
cells	NULL
and	NULL
especially	NULL
their	NULL
differentiation	NULL
in	NULL
the	NULL
spleen	NULL
are	NULL
largely	NULL
unknown	NULL
.	NULL

The	NULL
process	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
is	NULL
controlled	NULL
by	NULL
a	NULL
set	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
as	NULL
well	NULL
as	NULL
stage-	NULL
and	NULL
lineage-restricted	NULL
*	NULL
This	NULL
research	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Minerva	NULL
Foundation	NULL
,	NULL
Ger-many	NULL
,	NULL
The	NULL
Israel	NULL
Science	NULL
Foundation	NULL
founded	NULL
by	NULL
the	NULL
Academy	NULL
of	NULL
Sciences	NULL
and	NULL
Humanities	NULL
,	NULL
and	NULL
the	NULL
German-Israeli	NULL
Foundation	NULL
for	NULL
Scientific	NULL
Research	NULL
and	NULL
Development	NULL
(	NULL
to	NULL
I	NULL
.	NULL

S	NULL
)	NULL
and	NULL
by	NULL
the	NULL
Israel	NULL
Cancer	NULL
Research	NULL
Fund	NULL
and	NULL
the	NULL
Association	NULL
of	NULL
International	NULL
Cancer	NULL
Research	NULL
(	NULL
to	NULL
R.	NULL
D.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1784	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Both	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

|	NULL
Both	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
the	NULL
senior	NULL
authorship	NULL
of	NULL
this	NULL
work	NULL
.	NULL

**	NULL
Incumbent	NULL
of	NULL
the	NULL
Martha	NULL
S.	NULL
Sagon	NULL
Career	NULL
Development	NULL
Chair	NULL
.	NULL

7	NULL
}	NULL
Incumbent	NULL
of	NULL
the	NULL
Alvin	NULL
and	NULL
Gertruder	NULL
Levine	NULL
Career	NULL
Development	NULL
Chair	NULL
of	NULL
Cancer	NULL
Research	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
ad-dressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
972	NULL
--	NULL
8-984-4257	NULL
;	NULL
Fax	NULL
:	NULL
972-8-984-4141	NULL
;	NULL
E-mail	NULL
:	NULL
idit	NULL
.	NULL

shachar	NULL
@	NULL
weizmann.ac.il	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
genes	NULL
.	NULL

Recently	NULL
several	NULL
studies	NULL
implicated	NULL
NF-	NULL
«	NULL
B	NULL
as	NULL
a	NULL
major	NULL
regulator	NULL
of	NULL
the	NULL
final	NULL
stage	NULL
of	NULL
B	NULL
cell	NULL
maturation	NULL
.	NULL

Cells	NULL
deficient	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
,	NULL
c-Rel	NULL
and	NULL
RelA	NULL
,	NULL
were	NULL
found	NULL
to	NULL
be	NULL
arrested	NULL
at	NULL
the	NULL
immature	NULL
stage	NULL
(	NULL
9	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
factors	NULL
are	NULL
essential	NULL
for	NULL
antigen-independent	NULL
B	NULL
cell	NULL
development	NULL
in	NULL
the	NULL
spleen	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
I	NULL
«	NULL
Ba	NULL
overexpression	NULL
in	NULL
B	NULL
cells	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
mature	NULL
B	NULL
cell	NULL
population	NULL
(	NULL
10	NULL
)	NULL
,	NULL
supporting	NULL
the	NULL
notion	NULL
that	NULL
NF-kB	NULL
has	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
late	NULL
B	NULL
cell	NULL
differentiation	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
invariant	NULL
chain	NULL
(	NULL
Ii	NULL
)	NULL
,1	NULL
a	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
chaperone	NULL
,	NULL
plays	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
immature	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
spleen	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
mice	NULL
lacking	NULL
Ii	NULL
,	NULL
the	NULL
development	NULL
from	NULL
immature	NULL
to	NULL
mature	NULL
B	NULL
cells	NULL
is	NULL
impaired	NULL
,	NULL
and	NULL
B	NULL
cells	NULL
are	NULL
arrested	NULL
at	NULL
an	NULL
immature	NULL
stage	NULL
characterized	NULL
by	NULL
low	NULL
expression	NULL
levels	NULL
of	NULL
IgD	NULL
and	NULL
CD23	NULL
and	NULL
poor	NULL
response	NULL
to	NULL
T-independent	NULL
antigens	NULL
(	NULL
11-13	NULL
)	NULL
.	NULL

Recently	NULL
we	NULL
succeeded	NULL
in	NULL
disengaging	NULL
the	NULL
chaperonin	NULL
activity	NULL
of	NULL
Ii	NULL
from	NULL
its	NULL
role	NULL
in	NULL
B	NULL
cell	NULL
maturation	NULL
and	NULL
demonstrated	NULL
that	NULL
Ii	NULL
N-terminal	NULL
domain	NULL
is	NULL
directly	NULL
involved	NULL
in	NULL
the	NULL
maturation	NULL
of	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

However	NULL
,	NULL
at	NULL
present	NULL
,	NULL
the	NULL
molecular	NULL
mechanism	NULL
by	NULL
which	NULL
Ii	NULL
induces	NULL
B	NULL
cell	NULL
maturation	NULL
is	NULL
still	NULL
unknown	NULL
.	NULL

Because	NULL
B	NULL
cells	NULL
that	NULL
are	NULL
deficient	NULL
in	NULL
either	NULL
Ii	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
,	NULL
c-Rel	NULL
and	NULL
RelA	NULL
,	NULL
are	NULL
both	NULL
arrested	NULL
at	NULL
the	NULL
immature	NULL
stage	NULL
in	NULL
the	NULL
spleen	NULL
,	NULL
in	NULL
this	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
a	NULL
possible	NULL
link	NULL
between	NULL
Ti-induced	NULL
maturation	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
Ii	NULL
induces	NULL
maturation	NULL
by	NULL
activating	NULL
a	NULL
pathway	NULL
leading	NULL
to	NULL
up-regulation	NULL
of	NULL
transcription	NULL
mediated	NULL
by	NULL
the	NULL
p65	NULL
component	NULL
of	NULL
NF-kB	NULL
and	NULL
its	NULL
coactivator	NULL
,	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
Spleen	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
various	NULL
mice	NULL
at	NULL
6-8	NULL
weeks	NULL
of	NULL
age	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
)	NULL
.	NULL

B	NULL
cell	NULL
population	NULL
was	NULL
enriched	NULL
by	NULL
treating	NULL
the	NULL
splenocyte	NULL
suspension	NULL
with	NULL
antibodies	NULL
against	NULL
T	NULL
cell	NULL
surface	NULL
molecules	NULL
(	NULL
anti-Thy	NULL
1.2	NULL
,	NULL
CD4	NULL
,	NULL
and	NULL
CD8	NULL
;	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
,	NULL
Inc.	NULL
)	NULL
for	NULL
1	NULL
h	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
low	NULL
Tox-M	NULL
complement	NULL
(	NULL
Cederlane	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
87	NULL
°C	NULL
.	NULL

Cell	NULL
Transfection	NULL
Primary	NULL
B	NULL
Cells-The	NULL
method	NULL
used	NULL
was	NULL
adapted	NULL
from	NULL
a	NULL
procedure	NULL
described	NULL
previously	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Purified	NULL
Ii_~	NULL
B	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
50	NULL
ug/ml	NULL
lipopolysaccharide	NULL
from	NULL
Salmonella	NULL
typhosa	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
RPMI	NULL
medium	NULL
and	NULL
transfected	NULL
with	NULL
Trans-Fast	NULL
transfection	NULL
reagent	NULL
(	NULL
Promega	NULL
)	NULL
using	NULL
12	NULL
pl/4	NULL
ug	NULL
of	NULL
DNA	NULL
(	NULL
2	NULL
ug	NULL
of	NULL
pBabe-puro	NULL
Ii	NULL
construct	NULL
+	NULL
2	NULL
ug	NULL
of	NULL
empty	NULL
vector	NULL
or	NULL
4	NULL
ug	NULL
of	NULL
empty	NULL
vector	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
directions	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
collected	NULL
after	NULL
48	NULL
h	NULL
and	NULL
analyzed	NULL
for	NULL
their	NULL
cell	NULL
surface	NULL
marker	NULL
expression	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

I	NULL
«	NULL
B	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
p50	NULL
constructs	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
increase	NULL
of	NULL
IgD*	NULL
cells	NULL
was	NULL
calculated	NULL
by	NULL
subtracting	NULL
the	NULL
X	NULL
mean	NULL
value	NULL
of	NULL
IgD*	NULL
staining	NULL
of	NULL
empty	NULL
expression	NULL
plasmid	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
Ii	NULL
,	NULL
invariant	NULL
chain	NULL
;	NULL
FACS	NULL
,	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
;	NULL
TAF	NULL
,	NULL
TBP-associated	NULL
factor	NULL
.	NULL

*	NULL
D.	NULL
Matza	NULL
,	NULL
D.	NULL
Lantner	NULL
,	NULL
Y.	NULL
Bogoch	NULL
,	NULL
L.	NULL
Flaishon	NULL
,	NULL
R.	NULL
Heshkoviz	NULL
,	NULL
and	NULL
I.	NULL
Shachar	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
.	NULL

27208	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
27204	NULL
A	NULL
B	NULL
100	NULL
Vector	NULL
4	NULL
10	NULL
%	NULL
Plasmid	NULL
§	NULL
“	NULL
H	NULL
6	NULL
©	NULL
755	NULL
0	NULL
+	NULL
2	NULL
a	NULL
41	NULL
%	NULL
2	NULL
p31	NULL
oE	NULL
``	NULL
's	NULL
so	NULL
{	NULL
8	NULL
&	NULL
©	NULL
S	NULL
0	NULL
€	NULL
254	NULL
a	NULL
13	NULL
%	NULL
&	NULL
p31	NULL
+	NULL
IxB	NULL
€	NULL
8	NULL
-_	NULL
_	NULL
____E	NULL
p31	NULL
|	NULL
+	NULL
+	NULL
-	NULL
IgD	NULL
-	NULL
#	NULL
»	NULL
IB	NULL
-	NULL
+	NULL
11-82	NULL
|	NULL
-	NULL
-	NULL
+	NULL
50	NULL
a	NULL
8h	NULL
a	NULL
Vector	NULL
-	NULL
a	NULL
=	NULL
40-Plasmid	NULL
§	NULL
R	NULL
8	NULL
a	NULL
.	NULL

[	NULL
=	NULL
]	NULL
&	NULL
304	NULL
a	NULL
6	NULL
a	NULL
43	NULL
%	NULL
$	NULL
ee	NULL
i-	NULL
$	NULL
204	NULL
8	NULL
III	NULL
“	NULL
5	NULL
3	NULL
®	NULL
404	NULL
a	NULL
16	NULL
%	NULL
p65	NULL
+	NULL
IxB	NULL
g	NULL
-	NULL
_i	NULL
_|	NULL
8	NULL
pes	NULL
+	NULL
+	NULL
+	NULL
IB	NULL
-	NULL
IgD	NULL
-	NULL
»	NULL
Ls	NULL
+	NULL
p50	NULL
-	NULL
-	NULL
+	NULL
Fig	NULL
.	NULL

1.	NULL
p65	NULL
homodimers	NULL
are	NULL
required	NULL
for	NULL
the	NULL
B	NULL
cell	NULL
maturation	NULL
pathway	NULL
.	NULL

B	NULL
cells	NULL
from	NULL
Ii	NULL
'~	NULL
animals	NULL
were	NULL
purified	NULL
and	NULL
cultured	NULL
.	NULL

48	NULL
h	NULL
later	NULL
the	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
empty	NULL
expression	NULL
plasmid	NULL
(	NULL
Vector	NULL
plasmid	NULL
)	NULL
,	NULL
Ii	NULL
p31	NULL
or	NULL
11-82	NULL
expression	NULL
vectors	NULL
alone	NULL
,	NULL
or	NULL
cotransfected	NULL
with	NULL
an	NULL
undegradable	NULL
mutant	NULL
of	NULL
I	NULL
«	NULL
B	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
empty	NULL
plasmid	NULL
vector	NULL
,	NULL
p65	NULL
alone	NULL
,	NULL
or	NULL
p65	NULL
cotransfected	NULL
with	NULL
either	NULL
the	NULL
IB	NULL
or	NULL
p50	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
FACS	NULL
for	NULL
IgD	NULL
expression	NULL
.	NULL

A	NULL
and	NULL
C	NULL
show	NULL
a	NULL
representative	NULL
result	NULL
.	NULL

B	NULL
and	NULL
D	NULL
represent	NULL
five	NULL
different	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

and	NULL
dividing	NULL
it	NULL
to	NULL
the	NULL
same	NULL
X	NULL
mean	NULL
value	NULL
multiplied	NULL
by	NULL
100	NULL
%	NULL
.	NULL

293	NULL
Cells-298	NULL
cells	NULL
(	NULL
human	NULL
embryonic	NULL
kidney	NULL
fibroblasts	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
F12	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
standard	NULL
CaPO	NULL
,	NULL
method	NULL
.	NULL

For	NULL
reporter	NULL
assay	NULL
the	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
a	NULL
24-well	NULL
multidish	NULL
,	NULL
using	NULL
a	NULL
total	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
plasmid	NULL
.	NULL

Usually	NULL
,	NULL
25	NULL
ng	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
AP-1	NULL
reporters	NULL
were	NULL
used	NULL
,	NULL
together	NULL
with	NULL
500	NULL
or	NULL
800	NULL
ng	NULL
of	NULL
Ii	NULL
expression	NULL
plasmid	NULL
,	NULL
and	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
was	NULL
kept	NULL
by	NULL
adding	NULL
pBabe	NULL
vector	NULL
.	NULL

When	NULL
Gal4	NULL
luciferase	NULL
reporter	NULL
was	NULL
analyzed	NULL
5	NULL
ng	NULL
of	NULL
the	NULL
reporter	NULL
and	NULL
1-5	NULL
ng	NULL
of	NULL
DBD	NULL
fusion	NULL
plasmids	NULL
were	NULL
used	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Immunofluorescence	NULL
and	NULL
Flow	NULL
Cytometry	NULL
Invariant	NULL
chain-deficient	NULL
transfected	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
the	NULL
9.1	NULL
anti-IgD	NULL
(	NULL
Pharmingen	NULL
)	NULL
antibody	NULL
as	NULL
was	NULL
described	NULL
previously	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Electrophoresis	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
18	NULL
)	NULL
from	NULL
Ii	NULL
'~	NULL
primary	NULL
B	NULL
cells	NULL
or	NULL
from	NULL
293	NULL
cells	NULL
.	NULL

A	NULL
double	NULL
stranded	NULL
oligonucleotide	NULL
,	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
,	NULL
was	NULL
labeled	NULL
with	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
oligonucleotide	NULL
is	NULL
as	NULL
follows	NULL
:	NULL
5	NULL
'	NULL
GATCCAGAGGGGACTTTTCCGAGAG	NULL
3	NULL
'	NULL
;	NULL
55	NULL
GATCCTCTCG-GAAAGTCCCCTCTG	NULL
3	NULL
'	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
7	NULL
Spleen	NULL
B	NULL
cells	NULL
from	NULL
mice	NULL
are	NULL
arrested	NULL
at	NULL
the	NULL
immature	NULL
stage	NULL
.	NULL

We	NULL
have	NULL
developed	NULL
an	NULL
in	NULL
vitro	NULL
system	NULL
to	NULL
Invariant	NULL
Chain-induced	NULL
B	NULL
Cell	NULL
Maturation	NULL
Involves	NULL
NF-	NULL
«	NULL
B-TAF	NULL
;	NULL
;	NULL
105	NULL
analyze	NULL
B	NULL
cell	NULL
maturation	NULL
.	NULL

In	NULL
this	NULL
assay	NULL
primary	NULL
immature	NULL
B	NULL
cells	NULL
from	NULL
Ti-deficient	NULL
mice	NULL
can	NULL
differentiate	NULL
to	NULL
mature	NULL
cells	NULL
in	NULL
culture	NULL
,	NULL
by	NULL
introducing	NULL
Ii	NULL
expression	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.2	NULL
To	NULL
investigate	NULL
the	NULL
involvement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
Ii-induced	NULL
B	NULL
cell	NULL
maturation	NULL
,	NULL
we	NULL
cotransfected	NULL
an	NULL
undegradable	NULL
mutant	NULL
form	NULL
of	NULL
IB	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
along	NULL
with	NULL
p31	NULL
Ii	NULL
.	NULL

In	NULL
addition	NULL
we	NULL
introduced	NULL
the	NULL
1-82	NULL
Ii	NULL
fragment	NULL
(	NULL
Ii1-82	NULL
)	NULL
lacking	NULL
its	NULL
lumenal	NULL
domain	NULL
.	NULL

This	NULL
IxB	NULL
mutant	NULL
abolished	NULL
both	NULL
p31-	NULL
and	NULL
Ii1-82-mediated	NULL
maturation	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

As	NULL
p65/ReIA	NULL
is	NULL
a	NULL
direct	NULL
target	NULL
for	NULL
inhibition	NULL
by	NULL
and	NULL
is	NULL
also	NULL
associated	NULL
with	NULL
the	NULL
process	NULL
of	NULL
B	NULL
cell	NULL
maturation	NULL
,	NULL
it	NULL
is	NULL
plausible	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
p65/ReIA	NULL
is	NULL
a	NULL
downstream	NULL
effector	NULL
of	NULL
Ti-induced	NULL
maturation	NULL
.	NULL

If	NULL
so	NULL
overexpression	NULL
of	NULL
p65/RelA	NULL
should	NULL
induce	NULL
maturation	NULL
of	NULL
Ii~'~	NULL
primary	NULL
immature	NULL
B	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
p65/RelIA	NULL
overcame	NULL
the	NULL
developmental	NULL
arrest	NULL
of	NULL
the	NULL
Ii~'~	NULL
B	NULL
cells	NULL
and	NULL
directly	NULL
induced	NULL
maturation	NULL
,	NULL
and	NULL
its	NULL
effect	NULL
was	NULL
abolished	NULL
by	NULL
dominant	NULL
IB	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
specificity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
dimers	NULL
in	NULL
inducing	NULL
maturation	NULL
of	NULL
Ii-deficient	NULL
primary	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
analyzed	NULL
maturation	NULL
induction	NULL
by	NULL
p50-p65	NULL
dimer	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
p65	NULL
:	NULL
p65	NULL
complex	NULL
,	NULL
the	NULL
heterodimeric	NULL
complex	NULL
,	NULL
p65-	NULL
:	NULL
p50	NULL
,	NULL
was	NULL
unable	NULL
to	NULL
induce	NULL
differentiation	NULL
of	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

To	NULL
address	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Ii	NULL
induces	NULL
B	NULL
cell	NULL
maturation	NULL
via	NULL
NF-kB	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
Ii	NULL
expression	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
activity	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
we	NULL
used	NULL
human	NULL
293	NULL
cells	NULL
that	NULL
do	NULL
not	NULL
express	NULL
the	NULL
endogenous	NULL
Ii	NULL
gene	NULL
.	NULL

The	NULL
use	NULL
of	NULL
non-B	NULL
cells	NULL
for	NULL
studies	NULL
of	NULL
B	NULL
cell-specific	NULL
transcription	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
many	NULL
studies	NULL
to	NULL
provide	NULL
valuable	NULL
functional	NULL
information	NULL
for	NULL
transcription	NULL
factors	NULL
and	NULL
transcription	NULL
modulators	NULL
(	NULL
19	NULL
)	NULL
.	NULL

A	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
containing	NULL
two	NULL
tandem	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
and	NULL
a	NULL
minimal	NULL
core	NULL
promoter	NULL
was	NULL
transfected	NULL
,	NULL
along	NULL
with	NULL
the	NULL
expression	NULL
plasmid	NULL
for	NULL
Ii	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
24	NULL
h	NULL
later	NULL
.	NULL

As	NULL
a	NULL
control	NULL
NF-	NULL
«	NULL
B-mutated	NULL
or	NULL
AP-1-dependent	NULL
reporter	NULL
plasmids	NULL
were	NULL
similarly	NULL
analyzed	NULL
.	NULL

Microscopic	NULL
examination	NULL
showed	NULL
li-transfected	NULL
cells	NULL
to	NULL
have	NULL
the	NULL
same	NULL
healthy	NULL
morphology	NULL
as	NULL
untransfected	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
Ii	NULL
enhanced	NULL
the	NULL
constitutive	NULL
NF-	NULL
«	NULL
B-dependent	NULL
activity	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
columns	NULL
1-3	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B-mutated	NULL
reporter	NULL
displayed	NULL
negligible	NULL
activity	NULL
and	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
Ii	NULL
expression	NULL
(	NULL
columns	NULL
4-6	NULL
)	NULL
.	NULL

The	NULL
AP-1-dependent	NULL
reporter	NULL
gene	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
Ii	NULL
expression	NULL
(	NULL
columns	NULL
7-9	NULL
)	NULL
confirming	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
Ii	NULL
on	NULL
NF-kB	NULL
.	NULL

As	NULL
the	NULL
N-terminal	NULL
segment	NULL
of	NULL
Ii	NULL
(	NULL
p31	NULL
1-82	NULL
)	NULL
is	NULL
capable	NULL
of	NULL
promoting	NULL
B	NULL
cell	NULL
maturation	NULL
similar	NULL
to	NULL
the	NULL
wild	NULL
type	NULL
protein	NULL
,	NULL
we	NULL
next	NULL
analyzed	NULL
the	NULL
effect	NULL
of	NULL
this	NULL
mutant	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
activity	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
amino	NULL
acids	NULL
1-82	NULL
enhanced	NULL
the	NULL
constitutive	NULL
NF-	NULL
«	NULL
B-dependent	NULL
activity	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
the	NULL
full-length	NULL
protein	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
construct	NULL
of	NULL
Ii	NULL
lacking	NULL
part	NULL
of	NULL
its	NULL
cytosolic	NULL
domain	NULL
,	NULL
amino	NULL
acids	NULL
2-17	NULL
(	NULL
A	NULL
2-17	NULL
)	NULL
,	NULL
was	NULL
unable	NULL
to	NULL
enhance	NULL
this	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Ii	NULL
N-terminal	NULL
17	NULL
amino	NULL
acids	NULL
are	NULL
important	NULL
for	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
activity	NULL
.	NULL

A	NULL
major	NULL
pathway	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
involves	NULL
induction	NULL
of	NULL
its	NULL
nuclear	NULL
localization	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
Ii	NULL
expression	NULL
affects	NULL
this	NULL
process	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
293	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
empty	NULL
or	NULL
invariant	NULL
chain	NULL
expression	NULL
plasmids	NULL
(	NULL
efficiency	NULL
of	NULL
transfection	NULL
was	NULL
above	NULL
80	NULL
%	NULL
)	NULL
.	NULL

These	NULL
extracts	NULL
were	NULL
used	NULL
in	NULL
electrophoresis	NULL
mobility	NULL
shift	NULL
assay	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B-specific	NULL
probe	NULL
.	NULL

Similar	NULL
levels	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
were	NULL
found	NULL
in	NULL
control	NULL
or	NULL
Ti-expressing	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
Ii	NULL
does	NULL
not	NULL
induce	NULL
nuclear	NULL
transport	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
NF-	NULL
«	NULL
B-specific	NULL
as	NULL
incubation	NULL
of	NULL
these	NULL
extracts	NULL
with	NULL
antibodies	NULL
against	NULL
the	NULL
p65/ReIA	NULL
component	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
resulted	NULL
in	NULL
a	NULL
supershifted	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Ii	NULL
stimulates	NULL
transcription	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
through	NULL
a	NULL
pathway	NULL
that	NULL
is	NULL
independent	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
transport	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Ii	NULL
controls	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Invariant	NULL
Chain-induced	NULL
B	NULL
Cell	NULL
Maturation	NULL
Involves	NULL
NF-	NULL
«	NULL
B-TAF	NULL
;	NULL
;	NULL
105	NULL
A	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Stimulation	NULL
of	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
by	NULL
Ii	NULL
.	NULL

A	NULL
,	NULL
wild	NULL
type	NULL
(	NULL
w..	NULL
)	NULL
and	NULL
mutated	NULL
NF-xB	NULL
reporter	NULL
plasmids	NULL
containing	NULL
two	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
and	NULL
AP-1	NULL
reporter	NULL
plasmid	NULL
were	NULL
transfected	NULL
into	NULL
human	NULL
298	NULL
cells	NULL
,	NULL
together	NULL
with	NULL
either	NULL
empty	NULL
expression	NULL
vector	NULL
or	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
Ii	NULL
expression	NULL
vector	NULL
(	NULL
0.5	NULL
and	NULL
1	NULL
ug	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
,	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
reporter	NULL
alone	NULL
was	NULL
normalized	NULL
to	NULL
1	NULL
.	NULL

B	NULL
,	NULL
wild	NULL
type	NULL
NF-	NULL
«	NULL
B	NULL
reporter	NULL
plasmids	NULL
containing	NULL
two	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
were	NULL
transfected	NULL
into	NULL
human	NULL
298	NULL
cells	NULL
,	NULL
together	NULL
with	NULL
either	NULL
empty	NULL
expression	NULL
vector	NULL
or	NULL
with	NULL
Ii	NULL
p31	NULL
or	NULL
111-82	NULL
amino	NULL
acids	NULL
or	NULL
Ii	NULL
A	NULL
2-17	NULL
expression	NULL
vector	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
different	NULL
Ii-derived	NULL
proteins	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
using	NULL
IN1	NULL
antibody	NULL
for	NULL
full-length	NULL
(	NULL
FL	NULL
)	NULL
and	NULL
1-82	NULL
and	NULL
anti-CD74	NULL
(	NULL
San-ta	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
for	NULL
A2-17	NULL
.	NULL

C	NULL
,	NULL
298	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
empty	NULL
vector	NULL
or	NULL
Ii	NULL
expression	NULL
plasmid	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
above	NULL
80	NULL
%	NULL
as	NULL
deter-	NULL
c	NULL
mined	NULL
by	NULL
cotransfected	NULL
green	NULL
fluorescent	NULL
protein	NULL
plasmid	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
mobility	NULL
shift	NULL
assay	NULL
using	NULL
an	NULL
NF-kB-specific	NULL
probe	NULL
.	NULL

D	NULL
,	NULL
298	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
luciferease	NULL
reporter	NULL
plasmid	NULL
containing	NULL
five	NULL
Gal4	NULL
binding	NULL
sites	NULL
,	NULL
together	NULL
with	NULL
unsaturated	NULL
amounts	NULL
of	NULL
G4-p65	NULL
TAl	NULL
(	NULL
the	NULL
TAl	NULL
activation	NULL
domain	NULL
of	NULL
p65/Re	NULL
!	NULL

A	NULL
fused	NULL
to	NULL
the	NULL
GAL4	NULL
G4-E2A-AD2	NULL
DNA	NULL
binding	NULL
domain	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
Ii	NULL
expression	NULL
plasmid	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
.	NULL

Luciferase	NULL
units	NULL
were	NULL
measured	NULL
,	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
G4-p65	NULL
TAl	NULL
and	NULL
G4-E2A-AD2	NULL
were	NULL
normalized	NULL
to	NULL
1	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
represent	NULL
the	NULL
average	NULL
of	NULL
at	NULL
least	NULL
four	NULL
independent	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

Activation	NULL
fold	NULL
0	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
effect	NULL
of	NULL
Ii	NULL
is	NULL
directed	NULL
to	NULL
the	NULL
transcriptional	NULL
activation	NULL
function	NULL
of	NULL
p65/RelA	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
we	NULL
used	NULL
an	NULL
expression	NULL
plasmid	NULL
that	NULL
encodes	NULL
a	NULL
fusion	NULL
of	NULL
the	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
p65/ReIA	NULL
(	NULL
TAl	NULL
)	NULL
with	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
yeast	NULL
transcription	NULL
factor	NULL
Gal4	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
E2A	NULL
activation	NULL
domain	NULL
fused	NULL
to	NULL
Gal4	NULL
was	NULL
used	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
transfected	NULL
into	NULL
293	NULL
cells	NULL
,	NULL
along	NULL
with	NULL
a	NULL
luciferase	NULL
reporter	NULL
containing	NULL
upstream	NULL
Gal4-binding	NULL
sites	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
Ii	NULL
plasmid	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
Ii	NULL
strongly	NULL
and	NULL
specifically	NULL
stimulated	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Gal4p65	NULL
but	NULL
not	NULL
Gal4E2A	NULL
fusion	NULL
proteins	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
Ii	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
is	NULL
at	NULL
least	NULL
in	NULL
part	NULL
targeted	NULL
to	NULL
the	NULL
activation	NULL
function	NULL
of	NULL
p65/ReIA	NULL
.	NULL

TAF	NULL
;	NULL
jf105	NULL
is	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
general	NULL
transcription	NULL
factor	NULL
TFIID	NULL
,	NULL
which	NULL
is	NULL
enriched	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

TAF	NULL
;	NULL
{	NULL
105	NULL
appears	NULL
to	NULL
be	NULL
present	NULL
only	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
TFIID	NULL
complexes	NULL
and	NULL
therefore	NULL
is	NULL
likely	NULL
to	NULL
function	NULL
in	NULL
the	NULL
context	NULL
of	NULL
specific	NULL
genes	NULL
.	NULL

was	NULL
shown	NULL
to	NULL
act	NULL
as	NULL
an	NULL
activation	NULL
domain-specific	NULL
coactivator	NULL
of	NULL
p65/ReIA	NULL
homodimers	NULL
.	NULL

This	NULL
function	NULL
of	NULL
involves	NULL
its	NULL
direct	NULL
interaction	NULL
with	NULL
the	NULL
p65/RelIA	NULL
activation	NULL
domain	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
TAFL,105	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
B	NULL
cell	NULL
differ-entiation	NULL
,	NULL
we	NULL
employed	NULL
two	NULL
dominant	NULL
negative	NULL
forms	NULL
of	NULL
TAF	NULL
j	NULL
;	NULL
105	NULL
lacking	NULL
the	NULL
TFIID	NULL
interaction	NULL
region	NULL
in	NULL
the	NULL
Ti-mediated	NULL
B	NULL
cell	NULL
maturation	NULL
assay	NULL
.	NULL

TAF	NULL
f105ACA	NULL
452-472	NULL
is	NULL
a	NULL
double	NULL
mutant	NULL
of	NULL
that	NULL
is	NULL
unable	NULL
to	NULL
bind	NULL
p65/	NULL
RelA	NULL
see	NULL
Ref	NULL
.	NULL

22	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
TAF	NULL
;	NULL
,105AC	NULL
with	NULL
the	NULL
p31	NULL
or	NULL
1-82	NULL
Ii	NULL
fragment	NULL
abolished	NULL
mat	NULL
p31	NULL
FL	NULL
.-	NULL
-th	NULL
.	NULL

-all	NULL
_	NULL
.	NULL

_-1	NULL
2	NULL
3	NULL
27205	NULL
B	NULL
w	NULL
WK	NULL
w.t	NULL
.	NULL

NF-xB	NULL
reporter	NULL
[	NULL
C	NULL
mutated	NULL
NF-kB	NULL
reporter	NULL
§	NULL
AP-1	NULL
reporter	NULL
Activation	NULL
fold	NULL
PMFL	NULL
|	NULL
-	NULL
fo-	NULL
0	NULL
0-	NULL
-	NULL
$	NULL
=	NULL
pH	NULL
AZT	NULL
-	NULL
=	NULL
=	NULL
-	NULL
=	NULL
+	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
(	NULL
-	NULL
#	NULL
)	NULL
&	NULL
)	NULL
(	NULL
-	NULL
)	NULL
1	NULL
ro	NULL
r	NULL
4	NULL
&	NULL
D	NULL
eﬁy	NULL
¢	NULL
#	NULL
®	NULL
M	NULL
G4-p65	NULL
TA1	NULL
C	NULL
G4-E24-AD2	NULL
o	NULL
6	NULL
£	NULL
£	NULL
6	NULL
©	NULL
4	NULL
>	NULL
ka	NULL
)	NULL
<	NULL
2	NULL
0	NULL
G4-fusion	NULL
-	NULL
++	NULL
+o	NULL
+	NULL
p31	NULL
FL	NULL
_-	NULL
_-	NULL
_+	NULL
-__	NULL
*+	NULL
1	NULL
2003	NULL
4	NULL
5	NULL
uration	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Apparently	NULL
,	NULL
suppression	NULL
of	NULL
the	NULL
endogenous	NULL
TAF	NULL
;	NULL
;	NULL
105	NULL
activity	NULL
by	NULL
the	NULL
competing	NULL
dominant	NULL
negative	NULL
TAF	NULL
;	NULL
,105AC	NULL
prevented	NULL
the	NULL
maturation	NULL
process	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
cotransfection	NULL
of	NULL
TAFq105AC-ANF-	NULL
«	NULL
B	NULL
with	NULL
p31	NULL
Ii	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
maturation	NULL
process	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

This	NULL
result	NULL
further	NULL
supports	NULL
the	NULL
involvement	NULL
of	NULL
p65/ReIA	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
pathway	NULL
in	NULL
Ti-induced	NULL
B	NULL
cell	NULL
maturation	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
effect	NULL
of	NULL
TAFp105AC	NULL
on	NULL
Ti-induced	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
using	NULL
a	NULL
luciferase	NULL
reporter	NULL
assay	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
Ti-enhanced	NULL
NF-	NULL
«	NULL
B-dependent	NULL
activity	NULL
was	NULL
dramatically	NULL
inhibited	NULL
when	NULL
cotransfected	NULL
with	NULL
TAF	NULL
105AC	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
impaired	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
(	NULL
TAF	NULL
;	NULL
,	NULL
;	NULL
105AC-ANF-	NULL
«	NULL
B	NULL
)	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
Ti-induced	NULL
activity	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
are	NULL
directly	NULL
involved	NULL
in	NULL
li-mediated	NULL
B	NULL
cell	NULL
maturation	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Ii	NULL
as	NULL
a	NULL
chaperone	NULL
for	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
molecules	NULL
has	NULL
been	NULL
well	NULL
characterized	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
described	NULL
a	NULL
novel	NULL
role	NULL
for	NULL
Ii	NULL
.	NULL

In	NULL
mice	NULL
lacking	NULL
this	NULL
chain	NULL
,	NULL
B	NULL
cell	NULL
maturation	NULL
is	NULL
impaired	NULL
,	NULL
and	NULL
their	NULL
secondary	NULL
lymphoid	NULL
organs	NULL
are	NULL
enriched	NULL
with	NULL
immature	NULL
B	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
study	NULL
reveal	NULL
that	NULL
Ii	NULL
is	NULL
most	NULL
likely	NULL
a	NULL
signaling	NULL
molecule	NULL
that	NULL
regulates	NULL
this	NULL
maturation	NULL
step	NULL
by	NULL
inducing	NULL
a	NULL
specific	NULL
gene	NULL
expression	NULL
program	NULL
.	NULL

Essential	NULL
elements	NULL
in	NULL
this	NULL
process	NULL
are	NULL
the	NULL
p65	NULL
component	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
coactivator	NULL
a	NULL
subunit	NULL
of	NULL
the	NULL
basal	NULL
transcription	NULL
factor	NULL
TFIID	NULL
,	NULL
which	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
27206	NULL
40	NULL
Go	NULL
o	NULL
%	NULL
increase	NULL
of	NULL
IgD+	NULL
cells	NULL
-	NULL
bo	NULL
o	NULL
o	NULL
p31	NULL
1-82	NULL
TAF	NULL
|	NULL
105AC	NULL
TAF	NULL
;	NULL
105AC-ANF-	NULL
xB	NULL
5	NULL
4	NULL
7	NULL
3	NULL
&	NULL
3	NULL
{	NULL
C	NULL
0	NULL
T	NULL
€	NULL
2	NULL
]	NULL
O	NULL
T	NULL
_	NULL
l	NULL
l	NULL
p31	NULL
-	NULL
+	NULL
+	NULL
+	NULL
TAF	NULL
,	NULL
105AC	NULL
|	NULL
_	NULL
-	NULL
-	NULL
+	NULL
TAF	NULL
,	NULL
105AC-ANF-	NULL
KB	NULL
|	NULL
__	NULL
-	NULL
-	NULL
-	NULL
+	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Ii	NULL
stimulates	NULL
B	NULL
cell	NULL
maturation	NULL
through	NULL
p65/ReIA	NULL
and	NULL
TAF	NULL
,	NULL
,105	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
for	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
(	NULL
A	NULL
)	NULL
empty	NULL
expression	NULL
plasmid	NULL
,	NULL
p31	NULL
or	NULL
Ii1-82	NULL
alone	NULL
,	NULL
or	NULL
together	NULL
with	NULL
the	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
TAF	NULL
,	NULL
,105	NULL
(	NULL
TAF	NULL
;	NULL
,	NULL
,105AC	NULL
)	NULL
or	NULL
TAF	NULL
,	NULL
p105AC	NULL
A	NULL
452-472	NULL
(	NULL
TAF	NULL
,	NULL
,105AC-ANF-	NULL
«	NULL
B	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
FACS	NULL
analyzed	NULL
as	NULL
described	NULL
for	NULL
Fig	NULL
.	NULL

1	NULL
for	NULL
IgD	NULL
expression	NULL
.	NULL

The	NULL
graph	NULL
represents	NULL
the	NULL
results	NULL
of	NULL
four	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
wild	NULL
type	NULL
NF-	NULL
«	NULL
B	NULL
reporter	NULL
plasmid	NULL
containing	NULL
two	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
was	NULL
transfected	NULL
into	NULL
human	NULL
298	NULL
cells	NULL
,	NULL
together	NULL
with	NULL
either	NULL
empty	NULL
expression	NULL
vector	NULL
or	NULL
with	NULL
Ii	NULL
expression	NULL
vector	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
with	NULL
or	NULL
without	NULL
TAF	NULL
,	NULL
,105AC	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
or	NULL
TAF	NULL
,	NULL
,105AC-ANF-	NULL
«	NULL
B	NULL
(	NULL
1	NULL
umg	NULL
)	NULL
.	NULL

The	NULL
graph	NULL
represents	NULL
the	NULL
results	NULL
of	NULL
three	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

evidence	NULL
support	NULL
this	NULL
conclusion	NULL
.	NULL

First	NULL
,	NULL
maturation	NULL
by	NULL
Ii	NULL
was	NULL
suppressed	NULL
by	NULL
NF-	NULL
«	NULL
B-specific	NULL
inhibitors	NULL
,	NULL
I	NULL
«	NULL
B	NULL
and	NULL
the	NULL
dominant	NULL
negative	NULL
mutant	NULL
of	NULL
TAFL,105	NULL
However	NULL
,	NULL
mutant	NULL
TAF	NULL
;	NULL
,105AC	NULL
lacking	NULL
the	NULL
p65	NULL
interaction	NULL
domain	NULL
failed	NULL
to	NULL
inhibit	NULL
Ti-induced	NULL
maturation	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
that	NULL
p65/	NULL
RelA	NULL
could	NULL
efficiently	NULL
overcome	NULL
the	NULL
B	NULL
cell	NULL
maturation	NULL
block	NULL
of	NULL
Ti-deficient	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
differentiation	NULL
induced	NULL
by	NULL
p65	NULL
is	NULL
similarly	NULL
inhibited	NULL
by	NULL
IxB	NULL
and	NULL
by	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
only	NULL
p65p65	NULL
but	NULL
not	NULL
p65	NULL
:	NULL
p50	NULL
NF-	NULL
«	NULL
B	NULL
dimeric	NULL
complexes	NULL
have	NULL
the	NULL
capacity	NULL
to	NULL
activate	NULL
the	NULL
maturation	NULL
process	NULL
,	NULL
a	NULL
result	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
TAFL,105	NULL
preferentially	NULL
associates	NULL
with	NULL
p65/ReIA	NULL
homodimer	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
p65p65	NULL
is	NULL
not	NULL
redundant	NULL
with	NULL
that	NULL
of	NULL
the	NULL
p50p65	NULL
complex	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
Invariant	NULL
Chain-induced	NULL
B	NULL
Cell	NULL
Maturation	NULL
Involves	NULL
NF-	NULL
«	NULL
B-TAF	NULL
;	NULL
;	NULL
105	NULL
this	NULL
stage	NULL
of	NULL
B	NULL
cell	NULL
differentiation	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
a	NULL
transcription	NULL
complex	NULL
of	NULL
p65-p65	NULL
and	NULL
is	NULL
an	NULL
essential	NULL
downstream	NULL
component	NULL
of	NULL
a	NULL
signaling	NULL
pathway	NULL
stimulated	NULL
by	NULL
Ii	NULL
that	NULL
leads	NULL
to	NULL
specific	NULL
gene	NULL
activation	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
is	NULL
activated	NULL
by	NULL
a	NULL
broad	NULL
range	NULL
of	NULL
extracellular	NULL
signals	NULL
.	NULL

A	NULL
major	NULL
pathway	NULL
in	NULL
regulating	NULL
NF-kB	NULL
activity	NULL
involves	NULL
its	NULL
nuclear	NULL
transport	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
characterized	NULL
additional	NULL
pathways	NULL
for	NULL
inducing	NULL
the	NULL
activation	NULL
potential	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
activation	NULL
domain	NULL
of	NULL
this	NULL
molecule	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
affected	NULL
by	NULL
several	NULL
signaling	NULL
pathways	NULL
including	NULL
cAMP-depend-ent	NULL
protein	NULL
kinase	NULL
(	NULL
24	NULL
)	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
25	NULL
)	NULL
,	NULL
Ras	NULL
(	NULL
25-27	NULL
)	NULL
,	NULL
and	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
p38	NULL
and	NULL
Erk	NULL
(	NULL
14	NULL
)	NULL
.	NULL

These	NULL
signaling	NULL
pathways	NULL
enhance	NULL
the	NULL
activation	NULL
function	NULL
of	NULL
p65	NULL
.	NULL

Our	NULL
experiments	NULL
show	NULL
that	NULL
one	NULL
possible	NULL
pathway	NULL
utilized	NULL
by	NULL
Ii	NULL
involves	NULL
modulation	NULL
of	NULL
the	NULL
p65/ReIA	NULL
activation	NULL
domain	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
this	NULL
event	NULL
augments	NULL
the	NULL
interaction	NULL
of	NULL
p65	NULL
with	NULL
coactivator	NULL
molecules	NULL
such	NULL
as	NULL
TAF	NULL
;	NULL
;	NULL
105	NULL
,	NULL
resulting	NULL
in	NULL
activation	NULL
of	NULL
specific	NULL
genes	NULL
required	NULL
for	NULL
B	NULL
cell	NULL
maturation	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
Ii	NULL
initiates	NULL
a	NULL
signaling	NULL
cascade	NULL
that	NULL
is	NULL
transmitted	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
activates	NULL
protein	NULL
kinases	NULL
leading	NULL
to	NULL
modulation	NULL
of	NULL
either	NULL
the	NULL
p65	NULL
activation	NULL
domain	NULL
or	NULL
its	NULL
coactivators	NULL
.	NULL

The	NULL
role	NULL
of	NULL
p65/ReIA	NULL
in	NULL
the	NULL
transition	NULL
from	NULL
immature	NULL
to	NULL
mature	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
spleen	NULL
is	NULL
consistent	NULL
with	NULL
recent	NULL
studies	NULL
showing	NULL
that	NULL
c-Rel	NULL
and	NULL
RelA	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
final	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
that	NULL
study	NULL
c-Rel	NULL
and	NULL
RelA	NULL
double	NULL
deficient	NULL
B	NULL
cells	NULL
,	NULL
like	NULL
Ti-deficient	NULL
cells	NULL
(	NULL
11-13	NULL
)	NULL
were	NULL
arrested	NULL
at	NULL
the	NULL
immature	NULL
stage	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
the	NULL
Ii	NULL
signal	NULL
essential	NULL
for	NULL
the	NULL
maturation	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
pathway	NULL
by	NULL
which	NULL
the	NULL
Ii	NULL
signal	NULL
is	NULL
transmitted	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
is	NULL
still	NULL
open	NULL
to	NULL
questions	NULL
.	NULL

Acknowledgments-We	NULL
gratefully	NULL
acknowledge	NULL
members	NULL
of	NULL
the	NULL
Shachar	NULL
and	NULL
Dikstein	NULL
laboratories	NULL
,	NULL
Richard	NULL
A.	NULL
Flavell	NULL
for	NULL
invaluable	NULL
advice	NULL
and	NULL
generous	NULL
gift	NULL
of	NULL
mice	NULL
,	NULL
and	NULL
Sandra	NULL
Moshonov	NULL
for	NULL
editing	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Eblich	NULL
,	NULL
A.	NULL
,	NULL
Martin	NULL
,	NULL
V.	NULL
,	NULL
Muller	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Rajewsky	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

4	NULL
,	NULL
573-583	NULL
.	NULL

Boekel	NULL
,	NULL
E.	NULL
,	NULL
Melchers	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Rolink	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
10183-1019	NULL
.	NULL

Allman	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Ferguson	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Lentz	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
and	NULL
Cancro	NULL
,	NULL
M.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
4481-4444	NULL
4	NULL
.	NULL

Rolink	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Andersson	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Melchers	NULL
,	NULL
F.	NULL
(	NULL
1998	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
3738-3748	NULL
5	NULL
.	NULL

Allman	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Ferguson	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Cancro	NULL
,	NULL
M.	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
2533-2540	NULL
6	NULL
.	NULL

Hardy	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
Carmack	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Shinton	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Kemp	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Hayakawa	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178	NULL
,	NULL
1218-1225	NULL
.	NULL

Thomas-Vaslin	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Freitas	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

1	NULL
,	NULL
287-246	NULL
.	NULL

Rajewsky	NULL
,	NULL
K.	NULL
(	NULL
19983	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
14	NULL
,	NULL
40-41	NULL
.	NULL

Grossmann	NULL
,	NULL
M.	NULL
,	NULL
O'Reilly	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Gugasyan	NULL
,	NULL
R.	NULL
,	NULL
Strasser	NULL
,	NULL
A.	NULL
,	NULL
Adams	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Gerondakis	NULL
,	NULL
S.	NULL
(	NULL
2000	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

19	NULL
,	NULL
6351-6360	NULL
10	NULL
.	NULL

Bendall	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
Sikes	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Oltz	NULL
,	NULL
E.	NULL
M.	NULL
(	NULL
1999	NULL
)	NULL
Mol	NULL
.	NULL

Immunol	NULL
.	NULL

86	NULL
,	NULL
187-195	NULL
11	NULL
.	NULL

Shachar	NULL
,	NULL
L	NULL
,	NULL
and	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
106-108	NULL
12	NULL
.	NULL

Kenty	NULL
,	NULL
G.	NULL
,	NULL
Martin	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
Van	NULL
Keer	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Bikoff	NULL
,	NULL
E.	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

160	NULL
,	NULL
606-614	NULL
13	NULL
.	NULL

Kenty	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Bikoff	NULL
,	NULL
E.	NULL
K.	NULL
(	NULL
1999	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

168	NULL
,	NULL
232-242	NULL
14	NULL
.	NULL

Vanden	NULL
Berghe	NULL
,	NULL
W.	NULL
,	NULL
Plaisance	NULL
,	NULL
S.	NULL
,	NULL
Boone	NULL
,	NULL
E.	NULL
,	NULL
De	NULL
Bosscher	NULL
,	NULL
K.	NULL
,	NULL
Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Fiers	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Haegeman	NULL
,	NULL
G.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
8285-3290	NULL
15	NULL
.	NULL

Elliott	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Drake	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Amigorena	NULL
,	NULL
S.	NULL
,	NULL
Elsemore	NULL
,	NULL
J.	NULL
,	NULL
Webster	NULL
,	NULL
P.	NULL
,	NULL
Mellman	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
,	NULL
681-694	NULL
16	NULL
.	NULL

McMahon	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
Norvell	NULL
,	NULL
A.	NULL
,	NULL
Levine	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
and	NULL
Monroe	NULL
,	NULL
J.	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
179	NULL
,	NULL
251-259	NULL
17	NULL
.	NULL

Shachar	NULL
,	NULL
L	NULL
,	NULL
Elliot	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Chasnoff	NULL
,	NULL
B.	NULL
,	NULL
Grewal	NULL
,	NULL
I.	NULL
S.	NULL
,	NULL
and	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunity	NULL
8	NULL
,	NULL
873-383	NULL
18	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
19	NULL
.	NULL

Henderson	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Calame	NULL
,	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16	NULL
,	NULL
163-200	NULL
20	NULL
.	NULL

Dikstein	NULL
,	NULL
R.	NULL
,	NULL
Zhou	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
87	NULL
,	NULL
137-146	NULL
21	NULL
.	NULL

Yamit-Hezi	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Dikstein	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

17	NULL
,	NULL
5161-5169	NULL
22	NULL
.	NULL

Yamit-Hezi	NULL
,	NULL
A.	NULL
,	NULL
Nir	NULL
,	NULL
S.	NULL
,	NULL
Wolstein	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Dikstein	NULL
,	NULL
R.	NULL
(	NULL
2000	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275	NULL
,	NULL
18180-18187	NULL
23	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14	NULL
,	NULL
649-683	NULL
24	NULL
.	NULL

Zhong	NULL
,	NULL
H.	NULL
,	NULL
Voll	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
and	NULL
Ghosh	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
1	NULL
,	NULL
661-671	NULL
25	NULL
.	NULL

Anrather	NULL
,	NULL
J.	NULL
,	NULL
Csizmadia	NULL
,	NULL
V.	NULL
,	NULL
Soares	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
and	NULL
Winkler	NULL
,	NULL
H.	NULL
(	NULL
1999	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274	NULL
,	NULL
18594-13603	NULL
26	NULL
.	NULL

Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Westwick	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Norris	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Der	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
24118-24116	NULL
27	NULL
.	NULL

Sanz	NULL
,	NULL
L.	NULL
,	NULL
Sanchez	NULL
,	NULL
P.	NULL
,	NULL
Lallena	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Diaz-Meco	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
and	NULL
Moscat	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
3044-3053	NULL
to	NULL
bo	NULL
t	NULL
go	NULL
i	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Invariant	NULL
Chain	NULL
Induces	NULL
B	NULL
Cell	NULL
Maturation	NULL
by	NULL
Activating	NULL
a	NULL
TAF	NULL
B-dependent	NULL
Transcription	NULL
Program	NULL
Didi	NULL
Matza	NULL
,	NULL
Orit	NULL
Wolstein	NULL
,	NULL
Rivka	NULL
Dikstein	NULL
and	NULL
Idit	NULL
Shachar	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2001	NULL
,	NULL
276:27203-27206.	NULL
doi	NULL
:	NULL
10.1074/jbc.M104684200	NULL
originally	NULL
published	NULL
online	NULL
May	NULL
22	NULL
,	NULL
2001	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
doi	NULL
:	NULL
10.1074/jbe.M104684200	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
27	NULL
references	NULL
,	NULL
14	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

